National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

MEDI-522

 A substance being studied in the treatment of some types of cancer and other conditions. MEDI-522 binds to a protein on the surface of blood vessels and may prevent the growth of new blood vessels that tumors need to grow. It may also prevent the spread of cancer. It is a type of antiangiogenesis agent, a type of metastasis inhibitor, and a type of monoclonal antibody. Also called Abegrin, etaracizumab, and humanized monoclonal antibody MEDI-522.



Previous Definitions:measles virus, measurable disease, mechlorethamine, mechlorethamine hydrochloride, MEDI-507
Next Definitions:medial supraclavicular lymph node, median, median survival time, median umbilical ligament, mediastinal pleura

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov